| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |